 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
||||||||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
|
||||||
 |
 |
 |
 |
 |
|
||||||
 |
 |
 |
 |
 |
|
||||||
MSC2007 • List of Invited Speakers and Session Chairs:
Back to daily program: click here.
Anthony Atala, M.D.
Professor, Chair, Department of Urology
Director, Institute for Regenerative Medicine
Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina
Frank Barry, Ph.D.
Professor of Cellular Therapy
Scientific Director, Regenerative Medicine Institute
National University of Ireland
Galway, Ireland
Paolo Bianco, Ph.D.
Dipartimento di Biopatologia Umana
Universita La Sapienza
Roma, Italy
Dominique Bonnet, Ph.D.
Senior Group Leader, Cancer Research UK
London Research Institute
Lincoln's Inn Fields Laboratories
London, England
Arnold Caplan, Ph.D.
Director, Skeletal Research Center
Case Western Reserve University
Cleveland, Ohio
Michael Chopp, Ph.D.
Vice Chair, Department of Neurology
Henry Ford Hospital
Detroit, Michigan
Stanley Dannemiller, D.V.M., M.S.
Director, Biological Resources Unit
Cleveland Clinic Lerner Research Institute
Cleveland, Ohio
Robert Deans, Ph.D.
Senior VP of Regenerative Medicine
Athersys, Inc
Cleveland, Ohio
Stanton Gerson, M.D.
Director, National Center for Regenerative Medicine
University Hospitals Case Medical Center
Case Western Reserve University
Cleveland, Ohio
Farshid Guilak, Ph.D.
Director, Orthopaedic Bioengineering Laboratory
Department of Surgery
Duke University Medical Center
Durham, North Carolina
Robert Harman, D.V.M., M.P.V.M.
President and CEO
Vet-Stem, Inc.
Poway, California
Marc Hedrick, M.D.
President
Cytori Therapeutics, Inc.
San Diego, California
Wolfgang Hofgartner, M.D.
Vice President, Research
Celgene Cellular Therapeutics
Summit, New Jersey
Armand Keating, M.D.
Director, Division of Hematology, Professor of Medicine
University of Toronto
Chief of Medical Services
Princess Margaret Hospital
Toronto, Ontario, Canada
Hillard Lazarus, M.D.
Director, Blood and Marrow Transplant Program
Ireland Cancer Center
University Hospitals Case Medical Center
Case Western Reserve University
Cleveland, Ohio
Katarina Le Blanc, M.D.
Department of Clinical Immunology
Karolinska Institute
Stockholm, Sweden
Robert Miller, Ph.D.
Professor, Department of Neurosciences
Case Western Reserve University
Cleveland, Ohio
C. Randal Mills, Ph.D.
President and CEO
Osiris Therapeutics, Inc.
Baltimore, Maryland
George Muschler, M.D.
Director, Clinical Tissue Engineering Center
Department of Biomedical Engineering
Cleveland Clinic Lerner Research Institute
Cleveland, Ohio
Jan Nolta, Ph.D.
Director, Stem Cell Program
University of California at Davis
Sacramento, California
Marc Penn, M.D.
Director, Bakken Heart-Brain Institute
Cleveland Clinic
Cleveland, Ohio
Mark Pittenger, Ph.D.
Capricore Inc.
Johns Hopkins University
Baltimore, Maryland
Linda Powers , J.D.
Toucan Capital Corporation
Johns Hopkins University
Bethesda, Maryland
Darwin Prockop, M.D., Ph.D.
Director, Center for Gene Therapy
Tulane University Health Science Center
New Orleans, Louisiana
Mahendra Rao, M.D., Ph.D.
Vice President, Regenerative Medicine
Invitrogen, Inc.
Carlsbad, California
Pablo Rubenstein, M.D.
Director, New York Blood Center
National Cord Blood Program
New York, New York
Paul Simmons, Ph.D.
Professor and Director, Stem Cell Institute
Brown Foundation Institute of Molecular Medicine
University of Texas Health Science Center at Houston
Houston, Texas
Alan Smith, Ph.D.
President and COO
Cognate Bioservices, Inc
Baltimore, Maryland
Luis Solchaga, Ph.D.
Scientific Director
Blood and Marrow Processing Laboratory
Hematopoietic Stem Cell Core Facility
Case Comprehensive Cancer Center
Cleveland, Ohio
Alan Trounson, MSc. Ph.D.
Professor of Stem Cell Sciences
Director, Monash Immunology and Stem Cell
Laboratories (MISCL) Monash University
Clayton, Victoria, Australia
Catherine Verfaillie, M.D.
Director, Stem Cell Institute Leuven
Katholieke Universiteit Leuven
Atrecht College
Leuven, Belgium
Peter Wernet, M.D., Ph.D.
Institute for Transplantation and Cell Therapeutics
Universitätsklinikum Düsseldorf / University Medical Center
Duesseldorf, Germany
Keith Wonnacott, Ph.D.
Chief, Cellular Therapies Branch
FDA/Center for Biologics Evaluation and Research
Rockville, Maryland
